Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 2 Study of Preoperative Radiation Therapy and Capecitabine (an Oral Fluoropyrimidine Carbamate) in Locally Advanced Rectal Cancer

NCT00122291 is registered in ClinicalTrials.gov with Alberta Health services as lead sponsor.

NCT NCT00122291
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00122291 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 2 Study of Preoperative Radiation Therapy and Capecitabine (an Oral Fluoropyrimidine Carbamate) in Locally Advanced Rectal Cancer
Lead sponsor
Alberta Health services
Phase
Phase 2
Overall status
Unknown status
Start date
January 31, 2002
Completion date
Not reported
Enrollment
66 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

neoplasm metastasis, rectal cancer